Results
1 -
9 of
9Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer, Cancer Chemotherapy and Pharmacology Pharmacokineticu2013Pharmacodynamic Modeling of the Hydroxy Lerisetron Metabolite L6-OH in Rats: An Integrated Parentu2013Metabolite Model, Pharmaceutical Research Subunit rotation models activation of serotonin 5-HT3AB receptors by agonists, Journal of Computer-Aided Molecular Design Altered Disposition and Effect of Lerisetron in Rats with Elevated Alpha1-acid Glycoprotein Levels, Pharmaceutical Research Functional group interactions of a 5-HT3R antagonist, BMC Biochemistry Identification of critical residues in loop E in the 5-HT3ASR binding site, BMC Biochemistry Lerisetron, Drugs in R & D